Charlie Lees
3y ago
I write about Crohn's disease and ulcerative colitis (IBD), digital health, diet, genetics and the microbiome. I am a passionate educator and innovator. I am a gastroenterologist and I run a busy IBD clinic. I am a Professor of Gastroenterology running a research team improving outcomes for people living with IBD. For more content please see charlielees.com and search Charlie Lees at YouTube.
Wearable devices are increasingly being used to manage chronic diseases.
The best use case is monitoring of blood sugar in diabetics with continuous glucose meters. The technology works, the biomarker is highly relevant, and many health tech firms have now developed apps wrapping a great user experience around this one key variable.
Other examples include smart inhalers for asthma / COPD, heart rhythm monitoring for cardiac disease, fitness monitoring, tracking of sleep disorders and wearable / app combinations for neurological disorders including Parkinson's disease and multiple sclerosis.
But what about IBD?
My dream device would passively monitor IBD in the background and act as an early warning system - a flare detector. One that can operate over a lifetime providing reassurance for patients while they go about living their best lives.
Smartwatches and fitness trackers: These devices can monitor physical activity, sleep patterns, and stress levels, which can all impact IBD symptoms. But they likely lack sensitivity and specificity to detect early flare states in IBD.
Wearable patches: These patches use a technology called microfluidics, which involves the manipulation of fluids on a microscale. The patches are designed to collect small amounts of sweat from the skin and analyse it for biomarkers of inflammation (eg IL-1b).
Point of care tests: Faecal calprotectin and finger prick blood testing at home both work, but even the best systems remain cumbersome and expensive for regular use. Good for intermittent use but not the full answer.
Smart pills: These are ingestible sensors that can track medication adherence and monitor GI function. Still in infancy but one to watch.
Smart toilets: These have the potential to collect and analyse stool samples to detect biomarkers of inflammation, track bowel function, monitor medication adherence, and analyse dietary components.
Opportunities and challenges for wearables in IBD
The biggest challenge in IBD is the sensitivity required to passively detect inflammation and the impact of lifestyle and environmental variables.
Physiological measurements via a fitness tracker - resting heart rate, heart rate variability, step count / strain - will be perturbed in IBD flares. But only at the point where the IBD is already clearly active. The rest of the time lifestyle and environmental variables will predominate - a bad night's sleep, a strenuous day, stressful events, alcohol or caffeine.
Smart toilets could be the most promising option for continuous monitoring, as they could potentially offer what we want from a passive monitoring system. It would only require a regular biological input from the user to yield a range of physiological measurements, including calprotectin, microbiome and metabolomic profiling and analysis of nutrient intake.
While the dream of a truly passive continuous monitoring system is still some way off, these new technologies offer exciting potential for improved IBD management.